Literature DB >> 30196382

Risk factors for early B cell recovery following single-dose rituximab therapy in Japanese children with steroid-dependent nephrotic syndrome.

Shuichiro Fujinaga1, Tomohiko Nishino2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30196382     DOI： 10.1007/s00467-018-4075-3

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN： 0931-041X            Impact factor:   3.714


× No keyword cloud information.
  3 in total

1.  Risk factors for early relapse during maintenance therapy after a single infusion of rituximab in children with steroid-dependent nephrotic syndrome.

Authors:  Shuichiro Fujinaga; Daishi Hirano
Journal:  Pediatr Nephrol       Date:  2013-11-17       Impact factor: 3.714

2.  Late-onset adverse events after a single dose of rituximab in children with complicated steroid-dependent nephrotic syndrome.

Authors:  Shuichiro Fujinaga; Kanako Ozawa; Koji Sakuraya; Akifumi Yamada; Toshiaki Shimizu
Journal:  Clin Nephrol       Date:  2016-06       Impact factor: 0.975

3.  Effect of different rituximab regimens on B cell depletion and time to relapse in children with steroid-dependent nephrotic syndrome.

Authors:  Julien Hogan; Claire Dossier; Thérésa Kwon; Marie-Alice Macher; Anne Maisin; Anne Couderc; Olivier Niel; Véronique Baudouin; Georges Deschênes
Journal:  Pediatr Nephrol       Date:  2018-08-14       Impact factor: 3.714
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.